Suppr超能文献

[乙酰肝素酶基因在子宫内膜异位症患者在位及异位子宫内膜中的表达]

[Expression of heparanase gene in eutopic and ectopic endometrium of women with endometriosis].

作者信息

Zong Li-li, Ma Li, Wang Xiao-ning, Zhang Jin-hua, He Yuan-li

机构信息

Department of Obstetrics and Gynecology, Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 2004 Jan;39(1):24-6.

Abstract

OBJECTIVE

To study the function of heparanase gene in the pathogenesis of endometriosis.

METHODS

In situ hybridization method was used to examine the heparanase mRNA expression in the eutopic and ectopic endometrium of patients with endometriosis (EM group, 23) and the eutopic endometrium of women without endometriosis (control group, 25).

RESULTS

(1) In EM group: The frequency of heparanase gene expression in eutopic was similar to that in ectopic endometrium. However the number of positive cells and the intensity of heparanase gene expression in ectopic endometrium was more than that in eutopic endometrium. The frequency of heparanase gene expression in proliferative phase was 83.3% (10/12), while in secretory phase it was 72.7% (8/11), the difference is not significant; (2) In control group: The frequency of heparanase gene expression in proliferative phase was 41.7% (5/12), while in secretory phase it was 7.7% (1/13), the difference is significant; (3) The frequency of heparanase gene expression in endometrium of patients with endometriosis and women without endometriosis were 78.3% (18/23) and 24.0% (6/25) respectively, the difference is significant.

CONCLUSIONS

Heparanase gene may play some roles in the pathogenesis of endometriosis, and it may participate the regulation of menstrual cycle, and that it may participate the regulation of menstrual cycle. It may be an important target of the trentment for endometriosis.

摘要

目的

研究乙酰肝素酶基因在子宫内膜异位症发病机制中的作用。

方法

采用原位杂交法检测子宫内膜异位症患者(子宫内膜异位症组,23例)在位及异位内膜组织中乙酰肝素酶mRNA的表达情况,并以非子宫内膜异位症患者的在位内膜组织作为对照(对照组,25例)。

结果

(1)子宫内膜异位症组:在位内膜组织中乙酰肝素酶基因表达阳性率与异位内膜组织相近,但异位内膜组织中乙酰肝素酶基因表达阳性细胞数及表达强度均高于在位内膜组织。增殖期乙酰肝素酶基因表达阳性率为83.3%(10/12),分泌期为72.7%(8/11),差异无统计学意义;(2)对照组:增殖期乙酰肝素酶基因表达阳性率为41.7%(5/12),分泌期为7.7%(1/13),差异有统计学意义;(3)子宫内膜异位症患者内膜组织中乙酰肝素酶基因表达阳性率为78.3%(18/23),非子宫内膜异位症患者内膜组织中乙酰肝素酶基因表达阳性率为24.0%(6/25),差异有统计学意义。

结论

乙酰肝素酶基因可能在子宫内膜异位症发病机制中起一定作用,可能参与月经周期的调节,有望成为子宫内膜异位症治疗的重要靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验